Citation Impact
Citing Papers
Does the new angiotensin converting enzyme inhibitor cilazapril prevent restenosis after percutaneous transluminal coronary angioplasty? Results of the MERCATOR study: a multicenter, randomized, double-blind placebo-controlled trial. Multicenter European Research Trial with Cilazapril after Angioplasty to Prevent Transluminal Coronary Obstruction and Restenosis (MERCATOR) Study Group.
1992
Potential etiologic and functional implications of genome-wide association loci for human diseases and traits
2009 Standout
Telmisartan, Ramipril, or Both in Patients at High Risk for Vascular Events
2008 Standout
Lipid peroxides and atherosclerosis.
1989
Comparison of performance of various sphygmomanometers with intra-arterial blood-pressure readings.
1978
Human microRNA-155 on Chromosome 21 Differentially Interacts with Its Polymorphic Target in the AGTR1 3′ Untranslated Region: A Mechanism for Functional Single-Nucleotide Polymorphisms Related to Phenotypes
2007
Dual blockade of the renin-angiotensin system in type 1 patients with diabetic nephropathy
2002
Bradykinin causes selective efferent arteriolar dilation during angiotensin I converting enzyme inhibition
1993
Inflammation and angiotensin II
2003
Independent β-Arrestin2 and Gq/Protein Kinase Cζ Pathways for ERK Stimulated by Angiotensin Type 1A Receptors in Vascular Smooth Muscle Cells Converge on Transactivation of the Epidermal Growth Factor Receptor
2009 StandoutNobel
Similarities between the discovery and regulation of pharmaceuticals and pesticides: in support of a better understanding of the risks and benefits of each
2011
Guidelines for the diagnosis and treatment of chronic heart failure
2001
Should We STOP Angiotensin Converting Enzyme Inhibitors/Angiotensin Receptor Blockers in Advanced Kidney Disease?
2016 Standout
Telmisartan
2001
The Effect of Irbesartan on the Development of Diabetic Nephropathy in Patients with Type 2 Diabetes
2001 Standout
Valsartan, Captopril, or Both in Myocardial Infarction Complicated by Heart Failure, Left Ventricular Dysfunction, or Both
2003 Standout
Effect of Captopril on Mortality and Morbidity in Patients with Left Ventricular Dysfunction after Myocardial Infarction
1992 Standout
Peripheral arterial vasodilation hypothesis: A proposal for the initiation of renal sodium and water retention in cirrhosis
1988 Standout
Renoprotective Effect of the Angiotensin-Receptor Antagonist Irbesartan in Patients with Nephropathy Due to Type 2 Diabetes
2001 Standout
Elderly heart failure patients with drug-induced serious hyperkalemia
2000
Debate: angiotensin-converting enzyme inhibitors versus angiotensin II receptor blockers—a gap in evidence-based medicine
2003
MicroRNA target site polymorphisms and human disease
2008
Intrarenal angiotensin II and hypertension
2003
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Aldosterone and antialdosterone therapy in congestive heart failure
1993
Developmental adaptation of the mouse cardiovascular system to elastin haploinsufficiency
2003
A hard look at angiotensin receptor blockers in heart failure
2004
Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial
2003 Standout
Chronic kidney disease
2011 Standout
A New Equation to Estimate Glomerular Filtration Rate
2009 Standout
How prevalent is hyperkalemia and renal dysfunction during treatment with spironolactone in patients with congestive heart failure?
2004
Screening of the Pan-African Natural Product Library Identifies Ixoratannin A-2 and Boldine as Novel HIV-1 Inhibitors
2015 StandoutNobel
Preventing or reducing late side effects of radiation therapy: radiobiology meets molecular pathology
2006 Standout
Evidence-based interventions to improve patient compliance with antihypertensive and lipid-lowering medications
2005
Williams–Beuren Syndrome
2010 Standout
A Randomized Trial of the Angiotensin-Receptor Blocker Valsartan in Chronic Heart Failure
2001 Standout
Cardiac Resynchronization in Chronic Heart Failure
2002 Standout
Rates of Hyperkalemia after Publication of the Randomized Aldactone Evaluation Study
2004 Standout
Effects of Multisite Biventricular Pacing in Patients with Heart Failure and Intraventricular Conduction Delay
2001 Standout
Non-coding RNAs in human disease
2011 Standout
Isolation of a cDNA encoding the vascular type-1 angiotensin II receptor
1991 StandoutNature
Hypertension and current issues in compliance and patient outcomes
2000
Drugs targeting the renin–angiotensin–aldosterone system
2002
Metalloprotease inhibitor blocks angiotensin II-induced migration through inhibition of epidermal growth factor receptor transactivation
2002
Angiotensin-(1-7) and its receptor as a potential targets for new cardiovascular drugs
2005
Short- and long-acting angiotensin-converting enzyme inhibitors: A randomized trial of lisinopril versus captopril in the treatment of congestive heart failure
1989
Hyponatremia and Mortality among Patients on the Liver-Transplant Waiting List
2008 Standout
Physiology of Local Renin-Angiotensin Systems
2006 Standout
Plasma catecholamine level and portal venous pressure as guides to prognosis in patients with cirrhosis
1988
Prognostic value of arterial pressure, endogenous vasoactive systems, and renal function in cirrhotic patients admitted to the hospital for the treatment of ascites
1988
Dual blockade of the renin-angiotensin system versus maximal recommended dose of ACE inhibition in diabetic nephropathy
2003
Relationship of Blood Pressure Control to Adherence With Antihypertensive Monotherapy in 13 Managed Care Organizations
2006
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
1999 Standout
Vitamin E Consumption and the Risk of Coronary Disease in Women
1993 Standout
Transition‐Metal‐Catalyzed Direct Arylation of (Hetero)Arenes by CH Bond Cleavage
2009 Standout
Meta-analysis of observed mortality data from all-controlled, double-blind, multiple-dose studies of losartan in heart failure
2000
Activation of neurohumoral systems following acute myocardial infarction
1991
Aliskiren: the first renin inhibitor for clinical treatment
2008
Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited
2009 Standout
Rapid Measurement of B-Type Natriuretic Peptide in the Emergency Diagnosis of Heart Failure
2002 Standout
Adherence to Medication
2005 Standout
Physiology and Pathophysiology of Carnosine
2013 Standout
Renin-angiotensin system: biochemistry and mechanisms of action.
1977 Standout
Diagnosis and Management of the Metabolic Syndrome
2005 Standout
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult
2005 Standout
Molecular Recognition of Protein−Ligand Complexes: Applications to Drug Design
1997 Standout
Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial—the Losartan Heart Failure Survival Study ELITE II
2000
Exercise and Physical Activity for Older Adults
2009 Standout
Obesity and Cardiovascular Disease: Pathophysiology, Evaluation, and Effect of Weight Loss
2005 Standout
Adipose Tissue, Inflammation, and Cardiovascular Disease
2005 Standout
Control of renin release: A review of experimental evidence and clinical implications
1976
Overexpression of angiotensin AT 1 receptor transgene in the mouse myocardium produces a lethal phenotype associated with myocyte hyperplasia and heart block
1997 StandoutNobel
Vasopeptidase Inhibition
2003
Targeting G βγ signaling in arterial vascular smooth muscle proliferation: A novel strategy to limit restenosis
1999 StandoutNobel
Angiotensin-Converting Enzyme C-Terminal Catalytic Domain Is the Main Site of Angiotensin I Cleavage In Vivo
2007 StandoutNobel
Dual Blockade of the Renin-Angiotensin System for Cardiorenal Protection: An Update
2009
ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease: Executive Summary
2008 Standout
Role of Angiotensin Converting Enzyme Inhibitors in Essential and Renal Hypertension
1984
Pathogenic role of the renin–angiotensin system in modulating radiation-induced late effects
2005
Rationale, design, and baseline characteristics of 2 large, simple, randomized trials evaluating telmisartan, ramipril, and their combination in high-risk patients: the Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial/Telmisartan Randomized Assessment Study in ACE Intolerant Subjects with Cardiovascular Disease (ONTARGET/TRANSCEND) trials
2004
The dipeptide carnosine constricts rabbit saphenous vein as a zinc complex apparently via a serotonergic receptor.
1996
Worldwide emergence of resistance to antifungal drugs challenges human health and food security
2018 StandoutScience
Fibrosis — A Common Pathway to Organ Injury and Failure
2015 Standout
Review: Prospects for ARB in the next five years
2001
Physical Activity and Public Health in Older Adults
2007 Standout
Renin-Angiotensin-Aldosterone and Hypertension
1980
Boldine Ameliorates Vascular Oxidative Stress and Endothelial Dysfunction
2014
The Impact of Aging on Adrenergic Receptor Function: Clinical and Biochemical Aspects
1985 StandoutNobel
Beneficial effects of candesartan, an angiotensin‐blocking agent, on compensated alcoholic liver fibrosis ‐ A randomized open‐label controlled study
2012
Chemistry and Biology Of Multicomponent Reactions
2012 Standout
Medication Adherence
2009 Standout
Cardiovascular drugs in children: Angiotensin-converting enzyme inhibitors
1988
Utility of blood pressure monitoring outside of the clinic setting.
2002
Age and cardiovascular response adaptation. Determinants of an antihypertensive treatment concept primarily based on beta-blockers and calcium entry blockers.
1983
Recent developments in the design of angiotensin‐converting enzyme inhibitors
1985
Recommendations for Blood Pressure Measurement in Humans and Experimental Animals
2005 Standout
Molecular phenotyping for analyzing subtle genetic effects in mice: Application to an angiotensinogen gene titration
2002 StandoutNobel
Works of Brunner Hr being referenced
Physiologic studies with saralasin in animals.
1979
Angiotensin II receptor antagonists
2000
[Prognostic value of the renin-angiotensin system in response to salt restriction and prognosis of alcoholic ascitic cirrhosis].
1986
Pharmacokinetic-pharmacodynamic relationships of three angiotensin II receptor antagonists in normal volunteers.
1996
Renin subgroups in essential hypertension. Further analysis of their pathophysiological and epidemiological characteristics.
1973
Angiotensin II blockade in normal man and patients with essential hypertension. Blood pressure effects depending on renin and sodium balance.
1976
Kalemia during combined therapy with an angiotensin converting enzyme inhibitor and a potassium-sparing diuretic.
1987
Saralasin in human hypertension: the early experience.
1979
Effect of a new angiotensin converting enzyme inhibitor MK 421 and its lysine analogue on the components of the renin system in healthy subjects
2004
[Vasopressin in acute myocardial infarct: clinical implications].
1986
Effect of a new angiotensin converting enzyme inhibitor MK 421 and its lysine analogue on the components of the renin system in healthy subjects.
1981
Correlation between plasma concentration of cilazapril and haemodynamic and hormonal effects in healthy man.
1989
Plasma angiotensins under sustained converting enzyme inhibition with enalapril in normal humans.
1985
Orally active angiotensin‐converting enzyme inhibitor (SO 14,225) as a treatment for essential hypertension.
1979
IMPROVED BLOOD PRESSURE CONTROL BY MONITORING COMPLIANCE WITH ANTIHYPERTENSIVE THERAPY
1999
Angiotensin-converting enzyme inhibition by hydroxamic zinc-binding idrapril in humans.
1994
Ambulatory blood pressure measurement and antihypertensive therapy.
1989
Lack of a role of circulating bradykinin in the blood pressure response to acute angiotensin converting enzyme inhibition in rats.
1987
RHC 3659: a new orally active angiotensin converting enzyme inhibitor in normal volunteers.
1981